A completely new classification of diabetes which also predicts the risk of serious complications and provides treatment suggestions. We are now seeing the first results of ANDIS - a study covering ...
Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type ...
Results from the first 70 days of the Virta Clinic trial suggest the historic dietary approach to management of type 2 diabetes has been all wrong. Type 2 diabetes (T2D) has long been viewed as a ...
For more than 30 years, Yale endocrinologist Kevan Herold has been researching treatments for Type 1 diabetes (T1D). For just as long, he’s been the principal investigator for multiple clinical trials ...
Type 2 diabetes mellitus (T2DM) is a multisystem disease comprising numerous metabolic defects that contribute to the development of hyperglycemia. Although insulin resistance in the skeletal muscle ...
Gaede and colleagues [3] have now reported their findings of a median of 21 years (13 years beyond the end of the 7.8-year trial) of follow-up. Patients who received intensive therapy were 45% less ...
This year marks the centenary of one of the biggest medical breakthroughs in history - the discovery of insulin. It began a century of innovation in which the lives of millions of people with type 1 ...
Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type ...
Early trials of tight glycemic control, such as the Diabetes Control and Complications Trial in type 1 diabetes and the UK Prospective Diabetes Study (UKPDS) demonstrated what has come to be known as ...
A completely new classification of diabetes which also predicts the risk of serious complications and provides treatment suggestions. We are now seeing the first results of ANDIS - a study covering ...
Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type ...
Results from four recent randomized clinical trials suggest that using medications that offer glucose control while reducing the risk for cardiovascular disease could improve patient outcomes. Heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results